Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Identification of poor responders to mycophenolic acid pro-drugs in de novo kidney transplant recipients
2009-014997-16Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of mycophenolate sodium in kidney allograft rejection, sponsored by Medical University of Vienna. Primary endpoint: Biopsy-proven rejection. Started Oct 2009; status: completed.
02
Drugs
mycophenolate sodium
03
Conditions
kidney allograft rejection
Beyond the preview
Go deeper on 2009-014997-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014997-16.